Concepedia

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Li Tang, Yiran Zheng, Mariane B. Melo, Llian Mabardi, Ana P. Castaño, Yuqing Xie, Na Li, Sagar B. Kudchodkar, Hing C. Wong, Emily K. Jeng,

Nature Biotechnology · 2018 · 646 citations · 46 references

DOIFull text

Open access

Concepts

References

46

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

, , +17

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

Richard A. Morgan, James C. Yang, Mio Kitano et al. · Molecular Therapy · 2010 · 2.5K citations · Full text

, , +17

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

Willem W. Overwijk, Marc R. Theoret, Steven E. Finkelstein et al. · The Journal of Experimental Medicine · 2003 · 918 citations · Full text

, , +17

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

Christopher C. Kloss, Maud Condomines, Marc Cartellieri et al. · Nature Biotechnology · 2012 · 862 citations · Full text

, , +16

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.

John P. Leonard, Matthew L. Sherman, Gerald L. Fisher et al. · PubMed · 1997 · 814 citations

, , +16